Tianshui Zhongxing Bio-technology Co.,Ltd.

Symbol: 002772.SZ

SHZ

7.08

CNY

Market price today

  • -764.5012

    P/E Ratio

  • 44.3411

    PEG Ratio

  • 2.78B

    MRK Cap

  • 0.00%

    DIV Yield

Tianshui Zhongxing Bio-technology Co.,Ltd. (002772-SZ) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.15%

Operating Profit Margin

0.00%

Net Profit Margin

-0.00%

Return on Assets

-0.00%

Return on Equity

-0.00%

Return on Capital Employed

0.00%

Company general description and statistics

Sector: Consumer Defensive
Industry: Agricultural Farm Products
CEO:Mr. Boshu Gao
Full-time employees:5761
City:Tianshui
Address:Tianshui National Agricultural Science &
IPO:2015-06-26
CIK:

Tianshui Zhongxing Bio-technology Co.,Ltd. engages in the research and development, production, and sale of edible fungi in China. It offers mushrooms under the Xi Huang, Nüwa, and Zhongxing and other brands. The company was formerly known as Tianshui Zhongxing Bio-technology Ltd. and changed its name to Tianshui Zhongxing Bio-technology Co.,Ltd. in March 2012. Tianshui Zhongxing Bio-technology Co.,Ltd. was founded in 2005 and is headquartered in Tianshui, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.149% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.001%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.002%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.001% return, is a testament to Tianshui Zhongxing Bio-technology Co.,Ltd.'s adeptness in optimizing resource deployment. Tianshui Zhongxing Bio-technology Co.,Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.001%. Furthermore, the proficiency of Tianshui Zhongxing Bio-technology Co.,Ltd. in capital utilization is underscored by a remarkable 0.000% return on capital employed.

Stock Prices

Tianshui Zhongxing Bio-technology Co.,Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $7.84, while its low point bottomed out at $7.72. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Tianshui Zhongxing Bio-technology Co.,Ltd.'s stock market.

Liquidity Ratios

Analyzing 002772.SZ liquidity ratios reveals its financial health of the firm. The current ratio of 194.91% gauges short-term asset coverage for liabilities. The quick ratio (113.75%) assesses immediate liquidity, while the cash ratio (97.19%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio194.91%
Quick Ratio113.75%
Cash Ratio97.19%

Profitability Ratios

002772.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -0.21% underscores its earnings before tax deductions. The effective tax rate stands at 1.04%, revealing its tax efficiency. The net income per EBT, 98.96%, and the EBT per EBIT, -239.70%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 0.09%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-0.21%
Effective Tax Rate1.04%
Net Income per EBT98.96%
EBT per EBIT-239.70%
EBIT per Revenue0.09%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.95, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 6270.40% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding114
Days of Inventory Outstanding300
Operating Cycle305.87
Days of Payables Outstanding40
Cash Conversion Cycle265
Receivables Turnover62.70
Payables Turnover9.02
Inventory Turnover1.22
Fixed Asset Turnover0.62
Asset Turnover0.28

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.92, and free cash flow per share, 0.52, depict cash generation on a per-share basis. The cash per share value, 4.54, showcases liquidity position. A payout ratio of -76.20 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.20, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.92
Free Cash Flow per Share0.52
Cash per Share4.54
Payout Ratio-76.20
Operating Cash Flow Sales Ratio0.20
Free Cash Flow to Operating Cash Flow Ratio0.56
Cash Flow Coverage Ratio0.14
Short Term Coverage Ratio0.31
Capital Expenditure Coverage Ratio2.27
Dividend Paid and Capex Coverage Ratio0.81
Dividend Payout Ratio0.07

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 38.72%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.72, we discern the balance between debt and equity financing. The long-term debt to capitalization, 27.64%, and total debt to capitalization, 42.01%, ratios shed light on its capital structure. An interest coverage of 0.02 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio38.72%
Debt Equity Ratio0.72
Long Term Debt to Capitalization27.64%
Total Debt to Capitalization42.01%
Interest Coverage0.02
Cash Flow to Debt Ratio0.14
Company Equity Multiplier1.87

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 4.90, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.41, reflects the portion of profit attributed to each share. The book value per share, 8.73, represents the net asset value distributed per share, while the tangible book value per share, 8.15, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share4.90
Net Income Per Share0.41
Book Value Per Share8.73
Tangible Book Value Per Share8.15
Shareholders Equity Per Share8.73
Interest Debt Per Share5.51
Capex Per Share-0.27

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -2.14%, indicates top-line expansion, while the gross profit growth, -14.74%, reveals profitability trends. EBIT growth, -41.36%, and operating income growth, -41.36%, offer insights into operational profitability progression. The net income growth, 0.78%, showcases bottom-line expansion, and the EPS growth, 2.50%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-2.14%
Gross Profit Growth-14.74%
EBIT Growth-41.36%
Operating Income Growth-41.36%
Net Income Growth0.78%
EPS Growth2.50%
EPS Diluted Growth2.50%
Weighted Average Shares Growth0.08%
Weighted Average Shares Diluted Growth0.08%
Dividends per Share Growth23.66%
Operating Cash Flow Growth6.24%
Free Cash Flow Growth68.46%
10-Year Revenue Growth per Share325.74%
5-Year Revenue Growth per Share91.11%
3-Year Revenue Growth per Share11.55%
10-Year Operating CF Growth per Share228.58%
5-Year Operating CF Growth per Share107.78%
3-Year Operating CF Growth per Share15.60%
10-Year Net Income Growth per Share69.87%
5-Year Net Income Growth per Share30.91%
3-Year Net Income Growth per Share28.17%
10-Year Shareholders Equity Growth per Share394.18%
5-Year Shareholders Equity Growth per Share19.82%
3-Year Shareholders Equity Growth per Share7.92%
10-Year Dividend per Share Growth per Share654.92%
5-Year Dividend per Share Growth per Share288.79%
3-Year Dividend per Share Growth per Share74.31%
Receivables Growth-65.03%
Inventory Growth1.52%
Asset Growth-7.54%
Book Value per Share Growth1.42%
Debt Growth-19.92%
R&D Expense Growth10.70%
SGA Expenses Growth26.11%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 4,207,563,639.36, captures the company's total value, considering both debt and equity. Income quality, 3.29, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.01, gauges operational efficiency, while the research and development to revenue, 0.60%, highlights investment in innovation. The ratio of intangibles to total assets, 5.51%, indicates the value of non-physical assets, and capex to operating cash flow, -20.40%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value4,207,563,639.36
Income Quality3.29
Sales General and Administrative to Revenue0.01
Research and Development to Revenue0.60%
Intangibles to Total Assets5.51%
Capex to Operating Cash Flow-20.40%
Capex to Revenue-5.55%
Capex to Depreciation-39.80%
Stock-Based Compensation to Revenue0.19%
Graham Number8.93
Return on Tangible Assets2.78%
Graham Net Net-1.41
Working Capital1,198,583,256
Tangible Asset Value3,204,055,527
Net Current Asset Value123,845,491
Invested Capital1
Average Receivables54,588,521
Average Payables192,241,670.5
Average Inventory1,265,046,931.5
Days Sales Outstanding5
Days Payables Outstanding44
Days of Inventory On Hand310
ROIC3.20%
ROE0.05%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.83, and the price to book ratio, 0.83, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.61, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 14.20, and price to operating cash flows, 7.94, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.83
Price to Book Ratio0.83
Price to Sales Ratio1.61
Price Cash Flow Ratio7.94
Price Earnings to Growth Ratio44.34
Enterprise Value Multiple15.27
Price Fair Value0.83
Price to Operating Cash Flow Ratio7.94
Price to Free Cash Flows Ratio14.20
Price to Tangible Book Ratio0.92
Enterprise Value to Sales2.18
Enterprise Value Over EBITDA9.37
EV to Operating Cash Flow8.02
Earnings Yield5.05%
Free Cash Flow Yield13.21%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) on the SHZ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -764.501 in 2024.

What is the ticker symbol of Tianshui Zhongxing Bio-technology Co.,Ltd. stock?

The ticker symbol of Tianshui Zhongxing Bio-technology Co.,Ltd. stock is 002772.SZ.

What is company IPO date?

IPO date of Tianshui Zhongxing Bio-technology Co.,Ltd. is 2015-06-26.

What is company current share price?

Current share price is 7.080 CNY.

What is stock market cap today?

The market cap of stock today is 2784146280.000.

What is PEG ratio in 2024?

The current 44.341 is 44.341 in 2024.

What is the number of employees in 2024?

In 2024 the company has 5761.